224 related articles for article (PubMed ID: 37262103)
1. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
3. Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity.
Hardee JP; Martins KJB; Miotto PM; Ryall JG; Gehrig SM; Reljic B; Naim T; Chung JD; Trieu J; Swiderski K; Philp AM; Philp A; Watt MJ; Stroud DA; Koopman R; Steinberg GR; Lynch GS
Mol Metab; 2021 Mar; 45():101157. PubMed ID: 33359740
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
5. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
[TBL] [Abstract][Full Text] [Related]
6. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.
Janssen PM; Hiranandani N; Mays TA; Rafael-Fortney JA
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2373-8. PubMed ID: 16024571
[TBL] [Abstract][Full Text] [Related]
7. Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouse.
Ferry A; Messéant J; Parlakian A; Lemaitre M; Roy P; Delacroix C; Lilienbaum A; Hovhannisyan Y; Furling D; Klein A; Li Z; Agbulut O
J Physiol; 2020 Sep; 598(17):3667-3689. PubMed ID: 32515007
[TBL] [Abstract][Full Text] [Related]
8. Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.
Isaac C; Wright A; Usas A; Li H; Tang Y; Mu X; Greco N; Dong Q; Vo N; Kang J; Wang B; Huard J
J Orthop Res; 2013 Mar; 31(3):343-9. PubMed ID: 23097179
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
10. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS
Am J Pathol; 2016 Dec; 186(12):3246-3260. PubMed ID: 27750047
[TBL] [Abstract][Full Text] [Related]
11. Muscle structure influences utrophin expression in mdx mice.
Banks GB; Combs AC; Odom GL; Bloch RJ; Chamberlain JS
PLoS Genet; 2014 Jun; 10(6):e1004431. PubMed ID: 24922526
[TBL] [Abstract][Full Text] [Related]
12. Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy.
Alves FM; Kysenius K; Caldow MK; Hardee JP; Chung JD; Trieu J; Hare DJ; Crouch PJ; Ayton S; Bush AI; Lynch GS; Koopman R
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1541-1553. PubMed ID: 35249268
[TBL] [Abstract][Full Text] [Related]
13. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
[TBL] [Abstract][Full Text] [Related]
14. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
Rodrigues M; Echigoya Y; Fukada SI; Yokota T
J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
[TBL] [Abstract][Full Text] [Related]
15. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
16. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
17. Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.
Lu A; Poddar M; Tang Y; Proto JD; Sohn J; Mu X; Oyster N; Wang B; Huard J
Hum Mol Genet; 2014 Sep; 23(18):4786-800. PubMed ID: 24781208
[TBL] [Abstract][Full Text] [Related]
18. Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles.
Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Voss AA; Ren H
J Physiol; 2023 Mar; 601(5):961-978. PubMed ID: 36715084
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice.
Li H; Sun H; Qian B; Feng W; Carney D; Miller J; Hogan MV; Wang L
J Bone Miner Res; 2020 Apr; 35(4):738-752. PubMed ID: 31800971
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
